Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: November 26, 2021
Reporting Period: Nine months ended September 30, 2021
Context: This filing incorporates by reference a press release (Exhibit 99.1) containing financial results, interim condensed consolidated financial statements, and clinical/corporate updates.
Key Financial Metrics
The provided text serves as a cover document and does not contain specific numerical data. The filing states that financial results for revenue, profit, cash flow, margins, debt, and liquidity are detailed in the incorporated press release (Exhibit 99.1). Consequently, the filing text does not provide clear values for these metrics.
Material Changes
The filing text does not explicitly detail material changes versus prior periods. It references the attached press release for the comparison of financial results and clinical updates.
Guidance, Outlook, and Risks
The filing incorporates "Forward Looking Statements" from the press release but does not reproduce the specific guidance, outlook, management commentary, risks, or contingencies within this text. Investors must refer to Exhibit 99.1 for these details.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 26, 2021) for specific revenue, net loss, and cash position figures.
- Verify the clinical trial updates and corporate developments mentioned in the incorporated press release.
- Examine the "Forward Looking Statements" section in the press release for updated guidance and risk factors.
- Confirm the interim condensed consolidated financial statements included in the press release for detailed balance sheet and cash flow data.